IL17A and colonic neoplasm: Finally, Wu et al. (57) demonstrated that γδ T cells (γδ17) are the major source of IL-17 in human colon cancer, with the majority (80%) of the IL-17+ γδ T cells expressing Vδ1 and 20% expressing Vδ2.